Risk of dementia by exposure, HR (95% CI) | Additive interaction (95% CI) | Multiplicative interaction (95% CI) a | ||||||
---|---|---|---|---|---|---|---|---|
Glucosamine users and APOE ε4 non-carrier | Glucosamine users and APOE ε4 carrier | Glucosamine non-users and APOE ε4 non-carrier | Glucosamine non-users and APOE ε4 carrier | AP | RERI | SI | ||
Model 1c | 1 (Reference) | 2.74 (2.48–3.03) | 1.18 (1.10–1.28) | 2.95 (2.72–3.19) | −0.142 (−0.641, 0.136) | −0.388 (−0.641, −0.136) | 0.818 (0.718, 0.931) | 1.25 (1.11–1.41) P<0.001 |
Model 2d | 1 (Reference) | 2.93 (2.63–3.27) | 1.20 (1.10–1.31) | 3.04 (2.78–3.32) | −0.105 (−0.206, −0.004) | −0.308 (−0.592, −0.023) | 0.863 (0.754, 0.988) | 1.22 (1.08–1.38) P=0.002 |
Model 3e | 1 (Reference) | 2.75 (2.49–3.04) | 1.14 (1.05–1.24) | 2.80 (2.58–3.04) | −0.072 (−0.167, 0.024) | −0.197 (−0.451, 0.058) | 0.899 (0.784, 1.031) | 1.26 (1.12–1.42) P<0.001 |
Dementia subtypeb | ||||||||
AD | 1 (Reference) | 4.07 (3.38–4.89) | 0.95 (0.80–1.13) | 3.83 (3.26–4.50) | 0.069 (−0.063, 0.201) | 0.280 (−0.271, 0.832) | 1.101 (0.909, 1.333) | 1.28 (1.01–1.61) P=0.039 |
VD | 1 (Reference) | 2.72 (2.03–3.63) | 1.24 (0.99–1.56) | 3.00 (2.38–3.78) | −0.193 (−1.073, 0.688) | −0.523 (−2.459, −1.412) | 0.766 (0.234, 2.515) | 1.30 (0.92–1.83) P=0.137 |